chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 5 minutes of received the vaccine employee became pale and felt faint.  Employee was lowered to the floor and examined.  BP 122/64, alert and  oriented, HR 100.  Employee stated he was nervous and had not had eated that day.  Pt. received juice and a cookie.  Felt better after ingestion of food.  No hives, wheezing, or other symptoms of an allergic reaction.
Pfizer vaccine was administered outside reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------- HYPOTENSION 8/19/2021 DIARRHEA
Information has been received from a consumer reporting on his 75-year-old female wife, with no pertinent medical history or allergies, who on approximately 15-AUG-2007 (2 1/2 months ago) was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  On approximately 31-AUG-2007 (2 weeks after vaccination) the patient experienced "pain that is radiating from front to back".  "Sometimes the pain stays in the front or back area".  There is no other symptoms and no rash".  The consumer is concerned this is shingles related.  The patient sought medical attention by seeing different physicians.  On an unspecified date the patient had a MRI and other unspecified tests that were all negative.  At the time of the report the patient's status was not recovered.  A product quality complaint was not involved.  Additional information has been requested.
8/20/07 adm. Varivax (LA SQ); mom called 8/21/07 "warm to touch and red" PHN advised to use ice (not directly on skin) to arm, Tylenol for discomfort. 8/22/07 mom called back and PHN asked to bring child in; dk pin, s/o raised 40mm area, warm to touch; "itches"; no fever; PHN referred to pvt MD to evaluate. 8/22/07 pvt Md states "local reaction, tx with Prednisone and anti-histamines"
Headache, muscle aches (all over), dizziness,  flu symptoms, diarrhea, weakness,
pt recv vax 16MAY95 & on that evening 5-6 hrs post vax pt devel profuse sweating,low grade fever & was very tired;24hrs later pt recovered;
Shortly after vaccine patient reported feeling dizzy. The patient refused to lie down, just stated she felt dizzy. The patient was given a cold compress and orange juice shortly after, within 5 minutes the patient stated she felt fine. Patient was observed for 30 minutes before leaving clinic site. Patient was followed up with 2 hours after event and stated she felt fine.
A nonserious report of expired dose of vaccine administered has been received from a health care professional concerning a 68-year-old female patient. Neither medical history nor concomitant medications were provided. The patient received FluMist on 29-Jan-2008. FluMist is indicated 2-49 year olds. The FluMist had expired on 10-Jan-2008. The patient is a 68-year old. The reporter indicated that no adverse events have occurred since the time of the report. Rechallenge is not applicable. The reporter provided no causality assessment for the event. The reporting source of this spontaneous, thus the sponsor's comment is not applicable.
After 8 hours of administration, experienced  Fever for 8 hours (102.4F-101); frontal headaches; joint pain; chills
Pain left thigh 3/23 evening swelling, hardness 3/24 am. Mom called on call doctor gave Motrin. 3 red blotches arise anterior left thigh scattered and separate from injection site seen in office 3/27 am. On 3/27 min induration left lateral thigh no edema, minimal erythema, Bil popliteal fossae with rash.
Dizziness, SkinRash, RespDepression, Rash, UrticariaPruritus & Tachycardia Narrative:  Itching, rash, SOB. Given EPI-pen and sent to local ER.
Around 2:30pm on 4/9/21 (one day after vaccination) I got a Charlie horse in my right calf. I didn?t think much of it. About 20 minutes later when trying to get out of bed I got another Charlie horse in my left calf this time. This one was much more painful and intense. After it let up I laid there for a little longer and tried to get up when my leg calf, again, got another Charlie horse in the same place. This happened a total of 4 times, back to back to back to back. Each Charlie horse I had in my left calf was especially intense and painful, worse than any Charlie horse I?d ever had before. I don?t get Charlie horses often, but I have been a lifetime athlete so I?m familiar with the feeling. I had not previously worked out in the days leading up to my vaccine. I?m not even sure this is an adverse effect of the vaccine, I just didn?t know if anyone had had a similar reaction and have been made aware that blood clots have also been a concern with the J&J vaccine.  I?m also unsure if my Zoloft, which has a warning that it may cause dizziness, may have reacted with the vaccine to make me incredibly dizzy. But around 04:00am on 4/9/21 (I work night shift) I became increasingly dizzy making it difficult to perform the tasks at hand. Enough so that I had to sit down and even reading words off a computer screen made me dizzy. I couldn?t drive home from work at 07:30am that morning because I was concerned with my dizziness. It had subsided by the time I woke up at 02:00pm later that day.
Starting three days after injection, swollen lymph nodes and slight headache. Starting on day 6 post administration, arm was red, swollen, tender at injection site. Redness spread over the next 2 days. Medicated with OTC benadryl cream and symptoms resolved 11 days after injection. Patient reported fever of 100.4 on day 10 post administration.
Flu like symptoms for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms for 2-3 days) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms for 2-3 days). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms for 2-3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Dec-2021: Follow up received included no new information.
5/3/2022 SIMULATED HA ,  passed out and vomited at work. Taken to ER and held over night,
Post vax, the pt had a warm feeling in lower extremities, nausea, mild dyspnea. Resolved over 1 hour after Benadryl.
FELT REALLY BAD; BREAKING OUT IN SWEATS; A LITTLE WINDED; LEGS ARE HURTING; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination on left arm. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced felt really bad, breaking out in sweats, a little winded, legs are hurting, headache, nausea, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, and had not recovered from felt really bad, breaking out in sweats, headache, a little winded, legs are hurting, and fatigue. This report was non-serious.
Approximately starting at 9:00 pm 8/19/14 (day of vaccine), patient reported pain in neck radiating to engulf her head, causing a knife-stabbing like pain. She was taken to emergency room and while there pain subsided. She was not treated at the ER - per mother.
Post vax, the pt developed swollen glands, chills, malaise, headache, fatigue, and joint pain. The pt went to the ER because of viral meningitis. Follow-up info from a registered nurse indicated that the pt was released from the ER with a diagnosis of viral meningitis. It was indicated by the registered nurse that it was the pt who reported tat she had viral meningitis; this diagnosis was not confirmed by the registered nurse. Subsequently, the pt reported that she had "imporve a lot." Additional info has been requested.
Information has been received from a physician concerning a female patient who was vaccinated with a first dose of Gardasil and on April 11 or 12, 2007, was vaccinated IM with a second dose of Gardasil. Four to five hours after receiving the second injection the patient developed "severe swollen glands, laryngitis, a sore throat and a mild fever of 99 degrees". The physician reported that the patient had a mild reaction after her first injection. The patient saw her Primary Care Physician (PCP) and was treated with Claritin and with other medications that were not specified. The patient's outcome was unknown at the time of this report. Additional information has been requested.
On Friday September 10, at  7:00 pm, I began having symptoms of anxiety which triggered shortness of breath , heaviness in chest. I been feeling nauseous, confused, body tremors, difficulty falling asleep, tachycardia, nervousness cold feet and hands, mental exhaustion, loss of appetite that have not subsided until this day.
1wk post vax pt devel temp, staring spell, sz lasting 25-30min, T103.6, chills;rx phenobarb to control sz;
M.D. - FOR 10 YRS administered Non-PRESERVative vaccine (FLu) BECAUSE OF Previous problem (#23) SHE DIED 8/2019. PHARmaCisT insisted NO preservative AnD DiD NOT TELL me about ADJuvAnT in FluAD. I started severE JoinT PaiN by 9/29/20 - Similar to Osteoarthritis. Continued for 3 weeks. TreateD with X-StrenGTH TYLENOL.
I've had bursitis like symptoms for 8 months. Excruciating pain and limited range of movement.
Strong fatigue and accelerated heartbeat the evening of the shot. The following day, my pulse was racing at 153 BPM shine in the shower. After resting, laying down, the lowest it would go is 11 -107 BPM. We decided to go to the emergency office. I got an EKG, and by that time everything had slowed down and looked fine. A headache persisted. I've never had a resting pulse that high before. It was weird.
Severe breathing distress lasting 3 days  Diarrhea 2 days.  Injection site pain. Headache joint pAin Fatigue
Itch on Left foot within 30-45 minutes round red blotch formed w/blister in middle. During night, more itching on leg with 2 more red spots and blisters plus 3 on right leg. Used Listerine and Cortaid.
On 01/08/2022 I started feeling poorly. By the time I could get tested it was 01/10/2022 and I tested positive for it despite being fully vaccinated with booster. I saw my PCP and they gave me 4 shots of antibodies.
Person receiving shot stated that on the day after the vaccination her arm became sore and in the evening her arm was numb and she had swelling to right deltoid area
Temperature excursion with our Moderna Covid-19 vaccine; No adverse event; Poor quality product administered; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion with our Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Mar-2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion with our Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion with our Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion with our Moderna Covid-19 vaccine).    Concomitant medication was not provided.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-715674 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715674:Master case
Left deltoid soreness  day after and continuing for a couple days. Tiredness 24-48 post vaccine.  Vaccine site started noticeably itchy about 5 to 6 days after. Site always had a smaller red elongated "stripe" at the site of injection. A couple days later it became more  inflamed, red and larger, with distinct lines in the shape of an oval. Still very itchy and warm.
PROQUAD was given to a pregnant patient; This spontaneous prospective pregnancy report as received from a nurse referring to a currently 37 years old pregnant female patient. The patient had none pertinent medical history and none drug reactions or allergies. Concomitant medication included sterile diluent. The LMP and gestation were unknown except that she was early in the pregnancy based on lab hormone levels.  On unspecified date prior to 01-AUG-2019 vaccine titers were drawn and mumps were low; she was not immune to mumps. Office decided to give measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) because the patient's previous vaccination history was unknown. On 01-AUG-2019, the pregnant patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (0.5 ml once; lot number: R030801, expiration date: 22-APR-2020) subcutaneously, for prophylaxis. On that day, serum pregnancy test results initially looked negative so vaccine given then determined results actually were positive for pregnancy. Patient's present status was unknown. No treatment was given for the event. The pregnancy outcome was pending. The patient did not seek medical attention.
It was reported the patient experienced tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023NVX-US-000001492 (Novavax).  A 78-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 04Nov2023 as dose 1, single (Batch/Lot number: unknown) at the age of 78 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Nov2023, outcome "unknown", described as "It was reported the patient experienced tiredness".
contracted the Covid 19 virus; contracted the Covid 19 virus; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number and expiration date unknown), via an unspecified route of administration, on 18Mar2021 at age of 71-year) as a single dose for COVID-19 vaccination. The patient medical history was not reported. The patient's concomitant medications were not reported.  He had his first Covid 19 vaccine on 18Mar2021. He came down with the Covid 19 virus after receiving the vaccine and was in the hospital and was treated with plasma and antivirals. He doesn't know how he got the Covid 19 virus he wore his mask everywhere. Pt was hospitalized for the event. The clinical outcome of the event was unknown.   Information about the Lot/batch number has been requested.
Patient had no reaction at the clinic.  Patient is a medical doctor whose partner called in this death.  States patient had no  complaint on 1/13 nor 1/14 while at work.  States patient died at home on 1/15 a.m.  Physician who stated she was called to the patient's home @ 0157 1/15/2021 and found cyanotic from head to toe.  State girlfriend found him sitting in the chair a few minutes before they called her.  The Coroner did not order autopsy.  Did not sent patient to the hospital.  Sent him directly Funeral Home.  Death Certificate Number 123-2021-002593 list cause of death as pending.  I spoke with the patient's primary doctor who gave me the history of HTN, Diabetes, & High Cholesterol.  States he had not seen this patient since April 2020.  They were also friends and he was not aware of any medical problems.   The Coroner state she thinks patient has a heart attack.   Neither the Coroner nor PMD think death was related to COVID Vaccine.    Informed both that MSDH would have to complete VAERS.  Both voiced understanding.
pt recvd vax;at 2pm began screaming,emesis x 4;t 100; was fussy;seen in ofc,moaning at times but alert;total screaming x 4 hrs;back to nl in 24 hrs;
Coughing; loss of taste and smell; loss of taste and smell; This is a spontaneous report from a contactable consumer (reporting for himself). A 42-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL3302, expiration date unknown) via an unspecified route of administration in the left arm on 25Jan2021 (at 42 years old) at a SINGLE DOSE for COVID-19 immunization. The patient received the vaccine at a Hospital, reported as "Military Base." The patient had no medical history and had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID prior to vaccination, did not receive any other vaccines within 4 weeks prior to BNT162B2, and has not been tested for COVID since the vaccination. On 26Jan2021, the patient experienced coughing, loss of taste and smell. The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient treatment for the adverse events. Outcome of the events was not recovered. The events were reported as non-serious.
REDNESS, WARMTH, ERYTHEMA DISTAL TO THE INJECTION SITE PUT PROXIMAL TO THE ELBOW
I had the booster on Oct, 28 and suffered a stroke on Nov. 13.  Following transportation by ambulance to hospital, they did a CT scan of brain and determined a stroke from clot.  TPA was administered by IV.   Following 3 days in ICU, I came with a good prognsis.
Site even red; Like a big, round, size of a quarter rash/today it's even bigger; Became swollen again; It started itching above the site/itching/itchy; Her left arm started swelling; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Became swollen again), VACCINATION SITE ERYTHEMA (Site even red), VACCINATION SITE RASH (Like a big, round, size of a quarter rash/today it's even bigger), VACCINATION SITE SWELLING (Her left arm started swelling) and VACCINATION SITE PRURITUS (It started itching above the site/itching/itchy) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 063B22A) for COVID-19 vaccination.     Patient had no allergic reaction. Patient had no Medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. Patient did not received other vaccines within 1 month prior to Moderna COVID-19 vaccine. Patient did not had history of COVID-19.  The patient's past medical history included Anemia.   On 08-Nov-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 09-Nov-2022, the patient experienced VACCINATION SITE SWELLING (Her left arm started swelling). On 13-Nov-2022, the patient experienced VACCINATION SITE SWELLING (Became swollen again), VACCINATION SITE RASH (Like a big, round, size of a quarter rash/today it's even bigger) and VACCINATION SITE PRURITUS (It started itching above the site/itching/itchy). On 17-Nov-2022, the patient experienced VACCINATION SITE ERYTHEMA (Site even red). On 10-Nov-2022, VACCINATION SITE SWELLING (Her left arm started swelling) had resolved. At the time of the report, VACCINATION SITE SWELLING (Became swollen again), VACCINATION SITE ERYTHEMA (Site even red), VACCINATION SITE RASH (Like a big, round, size of a quarter rash/today it's even bigger) and VACCINATION SITE PRURITUS (It started itching above the site/itching/itchy) had not resolved.      The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   Patient was not on any concomitant medication.  Patient did not treated the rash with any medications  Treatment information was not provided.
Information has been received from a published article. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient # 23 of 32, a 28 year old female. On unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 28 year old female on an unspecified date was vaccinated with the first dose of RECOMBIVAX HB (lot number, route and site not reported). Concomitant therapy included prednisone and diclofenac. Fifteen days after vaccination, the patient developed uveitis. On an unspecified date the patient experienced meningitis. At the time of the report, the patient's outcome was not reported. The patient also experienced symptoms of headache, influenza-like symptoms and lymphandenopathy. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02347, WAES # 1004USA02349 to WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
Influenza vaccine given 9/14/18, febrile seizure 9/15/18 - atonic 2 minutes.